Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 340 Show results per page	View Search Criteria \| Help With Results

	Title				Phase				Protocol IDs

	Toxicity/Benefit Ratio Optimization of Chemotherapy in Colorectal Cancer (CRC) Patients by Determination of Individual Genotypic Determinants				Phase IV				COLOGEN NCT00138060
	Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer				Phase IV				GERCOR-TAUROX SANOFI-GERCOR-TAUROX, EU-20573, NCT00274885
	Preoperative Assessment for Synchronous Carcinoma or Polyps With MR Colonography				Phase IV				KA05030-MA KA05030, NCT00300547
	Elaboration of a Model for Predicting Efficacy of Monoclonal Antibodies (Cetuximab and Bevacizumab) in Patients With Colorectal Cancer and Liver Metastases				Phase IV				2005-401 NCT00327093
	Concentration of Ertapenem in Colorectal Tissue				Phase IV				01-07 NCT00535652
	Study of Biomarkers in Patients Undergoing Chemotherapy for Metastatic Colorectal Cancer				Phase IV				CHUL-BIO-COLON RECF0356, INCA-RECF0356, NCT00559676
	PSD Veritas Collagen Matrix Staple Line Reinforcement for Colorectal Surgery				Phase IV				CP1011, Rev C NCT00559013
	OBELIX Study: A Study of Avastin (Bevacizumab) in Combination With XELOX in Patients With Metastatic Cancer of the Colon or Rectum.				Phase IV				ML21380 NCT00577031
	Pharmacokinetic Study of Capecitabine in Elderly Cancer Patient (= 75 Years)				Phase IV				I07028 N° EudraCT : 2008-001195-7, NCT00812864
	Study to Evaluate the Clinical Benefit Response in Cancer Patients With Advanced Disease With AMT2003 Versus Placebo				Phase III, Phase II				AMT/P2CA/001 LC003AURON2005, NCT00332280


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute